UK MHRA Picks Pharmacovigilance For First AI Guideline
Companies Are Opting For Natural Language Processing To Speed Up Case Processing
In the first of a two-part series of articles on the use of artificial intelligence in pharmacovigilance, the Pink Sheet reports on what factors the UK medicines inspectors consider crucial to demonstrate the effectiveness of such AI systems. The second article will discuss how the balance between the use of AI and human resources is likely to change over time.
